1998
DOI: 10.1016/s0165-1781(97)00136-4
|View full text |Cite
|
Sign up to set email alerts
|

Decreased heart-period variability in patients with panic disorder: a study of Holter ECG records

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
68
1
9

Year Published

2000
2000
2014
2014

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 100 publications
(82 citation statements)
references
References 41 publications
4
68
1
9
Order By: Relevance
“…These findings should be viewed in the context of our previous findings of decreased HR or HP (heart period) variability in patients with panic disorder compared to control subjects and also the effects of yohimbine, suggesting a relative increase in cardiac vagal function in anxiety (Yeragani et al, 1992(Yeragani et al, , 1993a(Yeragani et al, , 1998. The main findings of this study are that sodium lactate, a drug that induces symptoms of panic anxiety in patients with panic disorder and a minority of normal control subjects, has produced a substantial decrease in LLE of unfiltered time series and also that of HF filtered series, which strongly suggests a vagolytic effect.…”
Section: Discussionmentioning
confidence: 53%
“…These findings should be viewed in the context of our previous findings of decreased HR or HP (heart period) variability in patients with panic disorder compared to control subjects and also the effects of yohimbine, suggesting a relative increase in cardiac vagal function in anxiety (Yeragani et al, 1992(Yeragani et al, , 1993a(Yeragani et al, , 1998. The main findings of this study are that sodium lactate, a drug that induces symptoms of panic anxiety in patients with panic disorder and a minority of normal control subjects, has produced a substantial decrease in LLE of unfiltered time series and also that of HF filtered series, which strongly suggests a vagolytic effect.…”
Section: Discussionmentioning
confidence: 53%
“…This increase in cardiovascular/cerebrovascular morbidity and mortality rates may be due to the existence of chronic cardiovascular (CV) risk in PD patients, illustrated either by elevated conventional risk factors such as smoking (Amering et al, 1999) or by chronic physiological states such as a sympathetic predominance as suggested by the decreased heart rate variability consistently described in PD patients (Yeragani et al, 1998). It appears that the increased risk for sudden cardiac death found in patients with high Nitric oxide and panic attacks N Lara et al levels of phobic anxiety, a common feature in PD patients, persists even after correction for conventional risk factors (Kawachi et al, 1994).…”
Section: Discussionmentioning
confidence: 99%
“…Kalp hızı değişkenliğinin uykuda incelenmesi, uyanıklıktaki bozucu dış faktörlerin etkisinden uzak, tonik otonomik işlevin değerlendirilmesinde daha değerli sonuçlar alınmasını sağlayabilir. Ancak panik bozukluğu hastalarında sınırlı sayıdaki uykuda kalp hızı değişkenliği çalışmalarından tutarlı sonuçlar elde edilememiştir (17)(18)(19)(20). Bu nedenle bu çalışmada ilaç kullanmayan panik bozukluğu hastalarının polisomnografi çalışması ile kalp hızı değişkenliğinin zaman ve frekans-alanında analizi amaçlanmıştır.…”
Section: Introductionunclassified